Form 8-K - Current report:
SEC Accession No. 0001437749-21-027619
Filing Date
2021-12-01
Accepted
2021-12-01 16:00:39
Documents
14
Period of Report
2021-11-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20211201_8k.htm   iXBRL 8-K 32185
2 EXHIBIT 99.1 ex_312601.htm EX-99.1 12734
  Complete submission text file 0001437749-21-027619.txt   182836

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20211124.xsd EX-101.SCH 3593
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20211124_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20211124_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20211124_pre.xml EX-101.PRE 11584
7 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20211201_8k_htm.xml XML 2556
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 211462862
SIC: 2836 Biological Products, (No Diagnostic Substances)